Revenue and profit growth: Total revenue rose 6% to $2.66 billion, while operating profit from reportable segments climbed 10% to $665 million for the first half of 2026. Adjusted EPS beats expectations: Adjusted earnings per share (EPS) increased 13% to 274.7 cents, surpassing analyst consensus estimates of approximately $2.40 per share.

Revenue surged 112% year-over-year to $2.58 billion, surpassing the consensus estimate of $2.56 billion and marking the fifth consecutive revenue beat since the company's IPO. Adjusted loss per share of $1.03 came in narrower than the analyst consensus of a $1.20 loss, while GAAP (Generally Accepted Accounting Principles) net loss widened to $626 million from $290 million a year ago.

Revenue climbed 57.3% year-over-year to $580.9 million, powered by higher precious metal and energy prices, yet fell short of the consensus estimate of approximately $619 million. Adjusted earnings per share (EPS) came in at $1.81 , below the FactSet consensus of $1.96 and well under the higher-end analyst forecasts near $2.16.

Non-GAAP EPS of $2.91 surged 40% year-over-year, handily beating the consensus estimate of approximately $2.41. Revenue rose 6% to $63.7 billion , missing the consensus estimate of roughly $65.2 billion but reflecting solid demand across the pharmaceutical distribution business.

Revenue surpassed $1 billion for the first time , reaching $1.01 billion and beating consensus estimates of $984.57 million by a comfortable margin. Adjusted earnings per share (EPS) came in at $3.23 , exceeding the analyst consensus of $2.95 by $0.28 and more than tripling the $0.88 reported in the same quarter last year.

Revenue surpassed expectations: Sea Limited reported second-quarter GAAP revenue of $7.8 billion, up 48.1% year-over-year and comfortably above the consensus estimate of approximately $7.1 billion. Earnings per share came in below forecasts: Diluted earnings per share (EPS) landed at $0.70, missing Wall Street estimates that ranged from $0.86 to $1.00, though it grew 7.7% from $0.65 in the same quarter a year ago.

Microsoft shares surged approximately 29.8% in the 30-day period through early August 2026, moving from around $385 to nearly $500. The explosive rally was triggered by Microsoft's fiscal Q4 2026 earnings on July 29, which beat consensus estimates across revenue, earnings, and cloud growth.

Upcoming second-quarter 2026 earnings release could provide updated guidance on revenue growth and margin expansion in gallium nitride (GaN) and silicon carbide (SiC) segments. Strategic positioning in high-efficiency power semiconductors positions the company to benefit from rising demand in electric vehicles (EVs), data centers, and renewable energy systems.

Completion of dosing in the REVEAL pivotal trial for TSHA-102 positions the company for key 6-month interim data and FDA feedback expected in the first half of 2027, potentially informing a Biologics License Application (BLA) pathway. Strong analyst consensus with a Buy rating from multiple firms and an average price target around $12.50 to $13.25 reflects optimism around clinical execution in Rett syndrome.

Price target: $10 represents the lowest analyst consensus target for TSHA and a psychologically significant round number, implying roughly 50% upside from recent trading levels around $6.66. Strongest bullish factors: Exceptional clinical data from the REVEAL pivotal trial showing 100% of Rett syndrome patients gained developmental milestones, multiple FDA expedited designations including Breakthrough Therapy status, and a cash runway extending into 2028.

Nike shares have declined approximately 7.2% over the last 30 days, with the stock trading near $41 as of mid-August 2026 — hovering just above its 52-week low of $40. JPMorgan downgraded NKE to Underweight on August 4, slashing its price target to $40 and warning that "Win Now" turnaround costs will pressure earnings through fiscal 2028.

JBLU shares rebounded +2.66% during regular trading Tuesday, recovering to approximately $5.79 after Monday's steep -7.08% selloff that closed at $5.64. The bounce follows Monday's double blow: Citigroup downgraded JBLU to Sell and slashed its price target to $5.30 from $6.60, while S&P cut the airline's credit rating to CCC+ on fuel cost and debt concerns.

Price Target: $8 represents the highest analyst price target currently on Wall Street for Opendoor Technologies, implying roughly 130% upside from recent trading levels around $3.48. Bullish Case: The company's "Opendoor 2.0" strategy under new CEO Kaz Nejatian emphasizes AI-driven efficiency, a capital-light product called Cash Plus, and an expanding U.S. footprint — all aimed at improving contribution margins and scaling transaction volume.

SPDR S&P 500 ETF Trust (SPY) tracks the S&P 500 Index with approximately 500 holdings, while Vanguard Large-Cap ETF (VV) follows the CRSP US Large Cap Index with roughly 446 holdings, resulting in slightly broader diversification for SPY. Both ETFs maintain heavy exposure to technology and other growth-oriented sectors, though VV offers a marginally lower expense ratio of 0.03% compared to SPY’s 0.09%.

Both BLDP and PLUG operate in the hydrogen fuel cell and clean energy sector, exposing them to similar macroeconomic and policy-driven catalysts. Recent quarterly results showed revenue growth for both companies, with BLDP reporting a notable improvement in gross margins and PLUG achieving break-even gross margins alongside increased full-year guidance.

Plug Power Inc. ( PLUG ) currently trades near $2.11, meaning a move to $5 would require approximately 137% upside — well beyond the consensus analyst price target of roughly $3.30. The strongest bull case rests on the company's Project Quantum Leap cost-cutting initiative, improving gross margins, and management's target of achieving positive EBITDA (earnings before interest, taxes, depreciation, and amortization) by the fourth quarter of 2026.

DASH delivered robust Q2 2026 revenue growth of 36% year-over-year to $4.45 billion, supported by 27% order growth, though GAAP net income declined 30% amid ongoing investments. GOOG reported Q2 2026 revenue of $119.8 billion, up 24%, with Google Cloud expanding 82% and operating margins reaching 34%, bolstered by significant equity gains.

DoorDash demonstrated robust revenue growth of 36% year-over-year in its most recent quarter, outpacing Meta Platforms' 28% revenue increase. Meta Platforms encountered post-earnings pressure tied to elevated artificial intelligence (AI) spending and softer guidance, while DoorDash showed mixed market reaction despite operational beats.

Virtus Terranova U.S. Quality Momentum ETF (JOET) employs a factor-based strategy targeting quality and momentum characteristics in large-cap U.S. stocks, while State Street SPDR S&P 500 ETF Trust (SPY) provides broad, market-cap-weighted exposure to the S&P 500 Index. JOET holds approximately 125 securities with roughly equal weighting among selected names, resulting in a more concentrated thematic tilt compared to SPY’s roughly 500 holdings.

OPFI plunged -20.07% to approximately $7.01 in Tuesday trading, extending its -6.70% decline during Monday's regular session, with the bulk of selling occurring in after-hours and premarket following its Q2 earnings release. The company reported Q2 adjusted EPS of $0.33, missing consensus estimates of $0.44–$0.46, while revenue of $145.2 million also came in below the $156 million Wall Street forecast.